Please use this identifier to cite or link to this item:
|Title:||ApolipoproteinL1 is expressed in papillary thyroid carcinomas||Authors:||Chidiac, Mounia
|Affiliations:||Department of Biology||Keywords:||Apolipoprotein L1
Papillary thyroid carcinoma
|Issue Date:||2016||Publisher:||Elsevier||Part of:||Pathology - Research and Practice||Volume:||212||Issue:||7||Start page:||631||End page:||635||Abstract:||
The apolipoprotein L (apoL) family has not yet been ascribed any definite patho-physiological function although the conserved BH3 protein domain suggests a role in programmed cell death. As repression of the regular apoptotic program is considered a hallmark of tumor progression, we investigated apoL expression in cancer. We show that the levels of one member of the family, apolipoprotein L1 (apoL1) is higher in papillary thyroid carcinoma compared to normal tissue. A combination of qRTPCR, immunohistochemistry and in situ hybridization allowed us to ascribe this increase to endogenous overexpression in carcinoma cells. Whether apoL1 plays an instrumental role in refraining cell death is the subject of ongoing molecular biology experiments.
|URI:||https://scholarhub.balamand.edu.lb/handle/uob/5187||ISSN:||03440338||DOI:||10.1016/j.prp.2016.04.004||Ezproxy URL:||Link to full text||Type:||Journal Article|
|Appears in Collections:||Department of Biology|
Show full item record
checked on Nov 25, 2023
checked on Nov 29, 2023
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.